1型糖尿病遗传风险评分在中国人群中区分1型与2型糖尿病
研究构建中国人群特异性1型糖尿病遗传风险评分(C-GRS),在独立验证队列中区分1型糖尿病与对照的AUC为0.871,区分1型与2型糖尿病的AUC为0.869,均优于欧洲来源GRS。
要点
- C-GRS由33个显著SNP构成,区分1型糖尿病与对照AUC=0.871。
- C-GRS区分1型与2型糖尿病AUC=0.869,优于欧洲GRS的0.793。
- C-GRS可能有助于中国人群1型糖尿病的精准诊断。
核心结论
- 由33个SNP构成的1型糖尿病C-GRS在中国人群中高度区分1型糖尿病风险,可能有助于区分1型与2型糖尿病。
研究设计与样本
- 全基因组关联分析纳入1303例1型糖尿病患者和2236例对照。
- 独立复制队列纳入501例1型糖尿病患者和853例对照,用于验证顶级常见变异关联。
- 独立验证队列纳入262例1型糖尿病患者、1080例2型糖尿病患者和208例对照,用于测试C-GRS准确性。
主要发现
- BMPER基因变异rs10232170为可能的1型糖尿病新位点(p=9.897×10-9)。
- 鉴定出13个DQA1-DQB1单倍型的标签SNP和12个非DQA1-DQB1位点。
- 整合HLA和非HLA区域33个显著SNP的C-GRS对1型糖尿病显示高区分度(AUC=0.876)。
- 在独立验证队列中,C-GRS区分1型糖尿病与对照的AUC为0.871,区分1型与2型糖尿病的AUC为0.869。
- C-GRS优于欧洲来源GRS:区分1型与对照AUC 0.871 vs 0.773,区分1型与2型AUC 0.869 vs 0.793。
关键数值与推荐
- C-GRS对1型糖尿病vs对照的AUC=0.871。
- C-GRS对1型糖尿病vs2型糖尿病的AUC=0.869。
- 欧洲GRS对1型糖尿病vs对照的AUC=0.773。
- 欧洲GRS对1型糖尿病vs2型糖尿病的AUC=0.793。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to generate a population-specific type 1 diabetes genetic risk score (GRS) and assess whether it could improve discrimination between type 1 diabetes and type 2 diabetes in a Chinese population. METHODS: We performed a genome-wide association analysis on 1303 individuals with type 1 diabetes and 2236 control individuals. An independent replication cohort of 501 individuals with type 1 diabetes and 853 control individuals was used to validate the top common variant associations. HLA typing data were used to identify tag SNPs for DQA1-DQB1 haplotypes. We integrated significant signals to construct a Chinese type 1 diabetes GRS (C-GRS). The accuracy of the C-GRS was tested in an independent validation cohort consisting of 262 individuals with type 1 diabetes, 1080 individuals with type 2 diabetes and 208 control individuals. RESULTS: We identified a variant, rs10232170, in BMPER as a possible novel type 1 diabetes locus (p=9.897×10-9). We identified tag SNPs for 13 DQA1-DQB1 haplotypes and 12 non-DQA1-DQB1 loci. Integrating 33 significant SNPs from HLA and non-HLA regions, C-GRS demonstrated high discriminative power for type 1 diabetes (AUC=0.876). It was tested in an independent validation cohort and showed high discrimination (AUC 0.871 for type 1 diabetes vs control group, 0.869 for type 1 diabetes vs type 2 diabetes). The C-GRS outperformed a European-derived GRS (0.871 vs 0.773, and 0.869 vs 0.793, respectively). CONCLUSIONS/INTERPRETATION: A type 1 diabetes C-GRS comprising 33 SNPs was highly discriminative of type 1 diabetes risk in the Chinese population and could aid in discriminating between type 1 diabetes and type 2 diabetes. This study highlights the potential of genetic information in improving prediction and precision diagnosis of type 1 diabetes in the Chinese population. DATA AVAILABILITY: The raw sequencing data and summary statistics of genomic DNA derived from human samples have been deposited at the China National Center for Bioinformation ( https://ngdc.cncb.ac.cn/omix ) under accession number PRJCA023730.
引用
- Hu J, Jiang G, Qin J, et al. A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population. Diabetologia. 2025. PMID: 40569436. doi:10.1007/s00125-025-06455-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。